American International Group, Inc. Revance Therapeutics, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$4.65 - $9.31 $1,720 - $3,444
-370 Reduced 0.85%
43,127 $212,000
Q4 2023

Feb 13, 2024
BUY
$5.81 - $11.2 $10,824 - $20,865
1,863 Added 4.47%
43,497 $382,000
Q3 2023

Nov 13, 2023
BUY
$11.47 - $25.07 $16,975 - $37,103
1,480 Added 3.69%
41,634 $477,000
Q2 2023

Aug 04, 2023
BUY
$24.7 - $37.61 $29,318 - $44,643
1,187 Added 3.05%
40,154 $1.02 Million
Q1 2023

May 12, 2023
BUY
$18.36 - $35.27 $14,229 - $27,334
775 Added 2.03%
38,967 $1.26 Million
Q4 2022

Feb 10, 2023
BUY
$18.32 - $30.66 $75,698 - $126,687
4,132 Added 12.13%
38,192 $705,000
Q3 2022

Nov 14, 2022
BUY
$14.33 - $28.47 $17,912 - $35,587
1,250 Added 3.81%
34,060 $920,000
Q2 2022

Aug 12, 2022
SELL
$11.52 - $20.4 $23,512 - $41,636
-2,041 Reduced 5.86%
32,810 $453,000
Q1 2022

May 13, 2022
SELL
$12.36 - $20.31 $30,319 - $49,820
-2,453 Reduced 6.58%
34,851 $680,000
Q4 2021

Feb 11, 2022
SELL
$12.46 - $27.87 $13,905 - $31,102
-1,116 Reduced 2.9%
37,304 $609,000
Q3 2021

Nov 12, 2021
SELL
$25.78 - $33.21 $23,537 - $30,320
-913 Reduced 2.32%
38,420 $1.07 Million
Q2 2021

Aug 13, 2021
BUY
$26.8 - $31.84 $71,180 - $84,567
2,656 Added 7.24%
39,333 $1.17 Million
Q1 2021

May 07, 2021
BUY
$24.03 - $29.97 $2,330 - $2,907
97 Added 0.27%
36,677 $1.03 Million
Q4 2020

Feb 12, 2021
SELL
$23.41 - $28.34 $24,580 - $29,757
-1,050 Reduced 2.79%
36,580 $1.04 Million
Q3 2020

Nov 04, 2020
BUY
$23.23 - $34.3 $67,320 - $99,401
2,898 Added 8.34%
37,630 $946,000
Q2 2020

Aug 12, 2020
BUY
$12.6 - $26.55 $52,617 - $110,872
4,176 Added 13.67%
34,732 $848,000
Q1 2020

May 04, 2020
BUY
$12.46 - $27.81 $28,570 - $63,768
2,293 Added 8.11%
30,556 $452,000
Q4 2019

Feb 05, 2020
BUY
$11.66 - $20.15 $5,328 - $9,208
457 Added 1.64%
28,263 $459,000
Q3 2019

Nov 08, 2019
SELL
$10.22 - $14.5 $1,982 - $2,813
-194 Reduced 0.69%
27,806 $361,000
Q2 2019

Aug 13, 2019
BUY
$10.67 - $15.49 $38,508 - $55,903
3,609 Added 14.8%
28,000 $363,000
Q1 2019

May 06, 2019
BUY
$15.4 - $20.39 $42,904 - $56,806
2,786 Added 12.9%
24,391 $384,000
Q4 2018

Feb 13, 2019
SELL
$18.06 - $24.96 $2,997 - $4,143
-166 Reduced 0.76%
21,605 $435,000
Q3 2018

Nov 09, 2018
BUY
$23.55 - $30.1 $9,255 - $11,829
393 Added 1.84%
21,771 $541,000
Q2 2018

Aug 08, 2018
BUY
$27.45 - $33.35 $114,548 - $139,169
4,173 Added 24.25%
21,378 $587,000
Q1 2018

May 07, 2018
BUY
$29.15 - $37.4 $51,449 - $66,011
1,765 Added 11.43%
17,205 $530,000
Q4 2017

Feb 09, 2018
BUY
$24.55 - $36.3 $9,869 - $14,592
402 Added 2.67%
15,440 $552,000
Q3 2017

Nov 09, 2017
BUY
$22.55 - $28.1 $339,106 - $422,567
15,038
15,038 $414,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email